Treatment with prophylactic oral anticoagulants and the risk of mortality in COVID-19 patients: a nationwide cohort study

BACKGROUND: Venous thromboembolism has been reported in patients with coronavirus disease 2019 (COVID-19). It remains unclear if premorbid use of prophylactic oral anticoagulation, for reasons other than COVID-19, protects against death in patients with COVID-19. The aim of this study was to estimat...

Descripción completa

Detalles Bibliográficos
Autores principales: Altaraihi, Sarah, Kamstrup, Peter, Eklöf, Josefin, Dyrby Johansen, Niklas, Biering-Sørensen, Tor, Sivapalan, Pradeesh, Jensen, Jens-Ulrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204852/
https://www.ncbi.nlm.nih.gov/pubmed/37228282
http://dx.doi.org/10.1183/23120541.00644-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204852/
https://www.ncbi.nlm.nih.gov/pubmed/37228282
http://dx.doi.org/10.1183/23120541.00644-2022

Ejemplares similares